Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(ADP-ribose) polymerase 1 pseudogene 1 (PARP1P1) is a nonfunctional copy of the poly(ADP-ribose) polymerase 1 (PARP1) gene, classified as a pseudogene. Unlike the functional PARP1 enzyme, which has significant roles in DNA repair and cancer biology, PARP1P1 does not encode a protein product and does not have known biological or clinical relevance. Its presence may have regulatory or evolutionary significance but is not considered a therapeutic target. Care should be taken not to confuse PARP1P1 with the functional and druggable PARP1 gene, which is a validated target in cancer therapy[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(ADP-ribose) polymerase 1 pseudogene 1 (PARP1P1).